Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal FKBP1A Primary Antibody for FACS, IHC (p) - ABIN1882082
Gerard, Debyser, Desender, Baert, Brandt, Baekelandt, Engelborghs: FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T. in Journal of neurochemistry 2008
Show all 2 Pubmed References
Chicken Monoclonal FKBP1A Primary Antibody for IF, IP - ABIN968189
Chen, Liu, Massague: Mechanism of TGFbeta receptor inhibition by FKBP12. in The EMBO journal 1997
Show all 2 Pubmed References
Human Monoclonal FKBP1A Primary Antibody for ELISA, WB - ABIN560904
Sitaraman, Chatterjee: Protein-protein interactions: an application of Tus-Ter mediated protein microarray system. in Methods in molecular biology (Clifton, N.J.) 2011
Human Polyclonal FKBP1A Primary Antibody for ELISA - ABIN560903
Biagiotti, Rossi, Bianchi, Giacomini, Pierigè, Serafini, Conaldi, Magnani: Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs. in Journal of controlled release : official journal of the Controlled Release Society 2011
Chemical Monoclonal FKBP1A Primary Antibody for IHC (p), WB - ABIN967396
Flanagan, Corthésy, Bram, Crabtree: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. in Nature 1991
Show all 3 Pubmed References
Acute tacrolimus treatment transiently increases hepcidin (show HAMP Antibodies) in wild-type mice. FKBP12 preferentially targets the BMP receptor (show BMPR1A Antibodies) ALK2 (show ACRV1 Antibodies). ALK2 (show ACRV1 Antibodies) mutants defective in binding FKBP12 increase hepcidin (show HAMP Antibodies) expression in a ligand-independent manner, through BMP-SMAD (show SMAD1 Antibodies) signaling.
FKBP51 (show FKBP5 Antibodies) is a central mediator of chronic pain.
We demonstrate that FKBP12 and its ligands impact multiple aspects of muscle function.
Fkbp1a-mediated regulation of Notch1 (show NOTCH1 Antibodies) plays an important role in intercellular communication between endocardium and myocardium.
FKBP12 is critically important in regulating trans-sarcolemmal ionic currents, predominately the voltage-gated Na+ current, I Na
the impact of simulated ischemia and reperfusion on expression of the calcium handling proteins FKBP12 and FKBP12.6 (show FKBP1B Antibodies), and intracellular calcium dynamics was investigated.
Data show that deletion of FKBP12 increased transforming growth factor-beta receptor activation and SMAD2 (show SMAD2 Antibodies)/3 signaling.
FKBP12 is a critical regulator of I(Na) and is important for cardiac arrhythmogenic physiology
a trimeric-interaction among calcineurin, FKBP12, and RyR (show RYR1 Antibodies) is important for the regulation of the RyR (show RYR1 Antibodies) channel activity and may play an important role in the Ca(2 (show CA2 Antibodies)+) signaling of muscle contraction and relaxation
FKBP12 binding to RyR1 (show RYR1 Antibodies) enhances the gain of skeletal muscle excitation-contraction coupling
Data indicate that S107 increased FKBP12 binding to RyR1 (show RYR1 Antibodies) in sarcoplasmic reticulum vesicles in the presence of reduced glutathione and the NO-donor NOC12.
A mutant with substitution at the sole cysteine residue of FKBP-12 (C23S) did not form dimers or trimers.
phosphorylation and K201 acted similarly to change the conformation of RyR1/2 and regulate FKBP12/12.6 binding.
expression higher in the silk gland and gut (show GUSB Antibodies)
A cDNA encoding the 12 kDa FKBP gene orthologue (FKBP12) in Bombyx mori was been isolated from both Bm-5 cultured cells and silk-gland tissue.
FKBP12 binding is required for full Met activation and everolimus can inhibit Met
Specifically tested on two model systems, the power of iSPOT is demonstrated to accurately predict the structures of a large protein-protein complex (TGFbeta (show TGFB1 Antibodies)-FKBP12) and a multidomain nuclear receptor homodimer (HNF-4alpha (show HNF4A Antibodies)), based on the structures of individual components of the complexes.
These results identify a novel function for FKBP12 in downregulating MDM2 (show MDM2 Antibodies), which directly enhances sensitivity of cancer cells to chemotherapy and nutlin-3 treatment.
Data show that FKBP12 (FK506 binding protein 1A)conformational transition Is coupled to histidine tautomerization.
Electrostatic effects on the folding stability of FKBP12
Findings indicate that mutant huntingtin (mHTT) aggregates can be transformed into benign species by isomerase FKBP12.
RyRs have been identified as important targets of FKBP12 and FKBP12.6 (show FKBP1B Antibodies), members of the immunophilin family
How phosphorylation of RyR (show RYR1 Antibodies) affects channel activity and whether proteins such as the FK-506 binding proteins (FKBP12 and FKBP12.6 (show FKBP1B Antibodies)) are involved in heart failure
Ultra-fast Shape Recognition with Atom Types--the discovery of novel bioactive small molecular scaffolds for FKBP12 and 11betaHSD1.
Selectivity within the FKBP (show FKBP7 Antibodies) family, in particular selective inhibition of FKBP12 or FKBP51 (show FKBP4 Antibodies), is possible. FKBP51 (show FKBP4 Antibodies) is a pharmacologically tractable target for stress-related disorders.
Stoichiometry of binding sites and FKBP (show FKBP7 Antibodies) exchange binding.
The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. The protein is a cis-trans prolyl isomerase that binds the immunosuppressants FK506 and rapamycin. It interacts with several intracellular signal transduction proteins including type I TGF-beta receptor. It also interacts with multiple intracellular calcium release channels, and coordinates multi-protein complex formation of the tetrameric skeletal muscle ryanodine receptor. In mouse, deletion of this homologous gene causes congenital heart disorder known as noncompaction of left ventricular myocardium. Multiple alternatively spliced variants, encoding the same protein, have been identified. The human genome contains five pseudogenes related to this gene, at least one of which is transcribed.
12 kDa FK506-binding protein
, 12 kDa FKBP
, FK506 Binding Protein12-T1
, FK506 binding protein12
, FK506 binding protein12-T2
, FK506-binding protein 1A
, PPIase FKBP1A
, immunophilin FKBP12
, peptidyl-prolyl cis-trans isomerase FKBP1A
, Immunophilin FKBP12
, binding protein
, FK506-binding protein
, FK506-binding protein 1
, FK506-binding protein 12
, FK506-binding protein 1A (12kD)
, FK506-binding protein, T-cell, 12-kD
, calstabin 1
, protein kinase C inhibitor 2
, FK506 binding protein 1B, 12.6 kDa
, FK506 binding protein 2 (13 kDa)
, FK506-binding protein 1 (12kD)
, FK506-binding protein 1a
, FK506 binding protein 1A, 12kDa
, fk506-binding protein
, FK506-binding protein-like
, FK 506-binding protein